The first pharmaceutical based premature ejaculation spray to be sold over the counter will be available for purchase in the States this year. Promescent will be presented at the American Urological Association’s Annual Meeting in Washington this month by G and H Brands LLC: the product that has all of the top urologists and sex therapists hailing this new spray as a breakthrough treatment for premature ejaculation.
Promescent is a topical spray that controls the hypersensitivity of the penis that causes many of the cases of premature ejaculation with the application of Lidocaine, its key ingredient.
No prescription will be required for this treatment and as the sensitivity of the penis varies greatly from man to man, the amount of treatment applied is optional making the product all the more attractive to men who want to control this type of sexual dysfunction. At first the premature ejaculation treatment will only be available in the US but considering the excitement surrounding its launch so far, it looks likely that the product will be available internationally in time.
Anyone wishing to use this product should be aware that it could cause a desensitisation in the female partner to a condom should really be used.